1. Home
  2. OBIO vs JWSM Comparison

OBIO vs JWSM Comparison

Compare OBIO & JWSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OBIO
  • JWSM
  • Stock Information
  • Founded
  • OBIO 2017
  • JWSM 2020
  • Country
  • OBIO United States
  • JWSM United States
  • Employees
  • OBIO N/A
  • JWSM N/A
  • Industry
  • OBIO Medicinal Chemicals and Botanical Products
  • JWSM Blank Checks
  • Sector
  • OBIO Health Care
  • JWSM Finance
  • Exchange
  • OBIO Nasdaq
  • JWSM Nasdaq
  • Market Cap
  • OBIO 291.7M
  • JWSM 302.5M
  • IPO Year
  • OBIO N/A
  • JWSM 2021
  • Fundamental
  • Price
  • OBIO $8.13
  • JWSM $11.11
  • Analyst Decision
  • OBIO Strong Buy
  • JWSM
  • Analyst Count
  • OBIO 2
  • JWSM 0
  • Target Price
  • OBIO $17.00
  • JWSM N/A
  • AVG Volume (30 Days)
  • OBIO 246.8K
  • JWSM 6.0K
  • Earning Date
  • OBIO 08-08-2024
  • JWSM 01-01-0001
  • Dividend Yield
  • OBIO N/A
  • JWSM N/A
  • EPS Growth
  • OBIO N/A
  • JWSM 75.00
  • EPS
  • OBIO N/A
  • JWSM 0.28
  • Revenue
  • OBIO $2,216,000.00
  • JWSM N/A
  • Revenue This Year
  • OBIO $17.90
  • JWSM N/A
  • Revenue Next Year
  • OBIO $10.51
  • JWSM N/A
  • P/E Ratio
  • OBIO N/A
  • JWSM $39.68
  • Revenue Growth
  • OBIO N/A
  • JWSM N/A
  • 52 Week Low
  • OBIO $4.22
  • JWSM $10.50
  • 52 Week High
  • OBIO $11.69
  • JWSM $11.25
  • Technical
  • Relative Strength Index (RSI)
  • OBIO 59.20
  • JWSM 50.17
  • Support Level
  • OBIO $7.48
  • JWSM $11.10
  • Resistance Level
  • OBIO $8.20
  • JWSM $11.14
  • Average True Range (ATR)
  • OBIO 0.61
  • JWSM 0.01
  • MACD
  • OBIO 0.01
  • JWSM -0.00
  • Stochastic Oscillator
  • OBIO 78.93
  • JWSM 20.00

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

About JWSM Jaws Mustang Acquisition Corp.

Jaws Mustang Acquisition Corp is a blank check company. it is formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business.

Share on Social Networks: